Brightspring Health Services Inc

Brightspring Health Services Inc(BTSG)股票分析

$60.870

-1.455 (-2.39%)收盤時

Loading chart…
最高
62.775
開盤
62.230
成交量加權均價
61.30
成交量
1.69M
市值
—
最低
60.270
成交金額
103.85M
企業價值/稅息折舊攤銷前利潤(TTM)
18.56

BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.

AI 分析 of Brightspring Health Services Inc (BTSG)

買進

Brightspring Health Services Inc is a good buy right now due to its current price of $63.74, which is below several analyst price targets, including $70 from Deutsche Bank and $80 from both KeyBanc and Morgan Stanley. The stock has shown strong momentum with a year-to-date change of +65.99% and a one-year change of +116.21%. However, the main risk is its high RSI of 83.243, indicating that the stock may be overbought in the short term.

估值指標

Brightspring Health Services Inc(BTSG)目前預期本益比為 22.17,5 年平均預期本益比為 27.11。

預期本益比

合理
5 年均值 P/E
27.11
目前P/E
22.17
高估
35.43
低估
18.80

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
12.91
目前EV/EBITDA
18.56
高估
17.01
低估
8.82

預期股價營收比

高估
5 年均值 P/S
0.38
目前P/S
0.69
高估
0.57
低估
0.19

Alphio AI 對 BTSG 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%BTSG

$28.42

情境價格

基

基準

基準 · 50%BTSG

$25.10

情境價格

悲

悲觀

悲觀 · 25%BTSG

$20.54

情境價格

持有 BTSG 的大戶

B

Braidwell LP

+ 持有BTSG

+15.28%

3個月報酬率

O

Oak Ridge Investments, LLC

+ 持有BTSG

+5.72%

3個月報酬率

L

LMR Partners LLP

+ 持有BTSG

+4.72%

3個月報酬率

K

KKR & Co. Inc.

+ 持有BTSG

-1.56%

3個月報酬率

S

Seven Grand Managers LLC

+ 持有BTSG

-1.91%

3個月報酬率

I

Infrastructure Capital Advisors, LLC

+ 持有BTSG

-2.27%

3個月報酬率

BTSG 常見問題 —— 由 Alphio AI 解答

BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care. It operates in the Healthcare sector (HOME HEALTH CARE SERVICES industry).

Brightspring Health Services Inc is a good buy right now due to its current price of $63.74, which is below several analyst price targets, including $70 from Deutsche Bank and $80 from both KeyBanc and Morgan Stanley. The stock has shown strong momentum with a year-to-date change of +65.99% and a one-year change of +116.21%. However, the main risk is its high RSI of 83.243, indicating that the stock may be overbought in the short term.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易